Faes Farma SA - Asset Resilience Ratio

Latest as of December 2025: 0.95%

Faes Farma SA (FAE) has an Asset Resilience Ratio of 0.95% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read FAE liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

€12.78 Million

≈ $14.94 Million USD Cash + Short-term Investments

Total Assets

€1.34 Billion

≈ $1.57 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Faes Farma SA's Asset Resilience Ratio has changed over time. See Faes Farma SA shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Faes Farma SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Faes Farma SA (FAE) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€12.78 Million	0.95%
Total Liquid Assets	€12.78 Million	0.95%

Asset Resilience Insights

Limited Liquidity: Faes Farma SA maintains only 0.95% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Faes Farma SA Industry Peers by Asset Resilience Ratio

Compare Faes Farma SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Faes Farma SA (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Faes Farma SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.95%	€12.78 Million ≈ $14.94 Million	€1.34 Billion ≈ $1.57 Billion	+0.02pp
2024-12-31	0.93%	€7.92 Million ≈ $9.26 Million	€853.08 Million ≈ $997.34 Million	-0.76pp
2023-12-31	1.69%	€13.10 Million ≈ $15.32 Million	€776.03 Million ≈ $907.26 Million	-9.90pp
2022-12-31	11.59%	€84.10 Million ≈ $98.32 Million	€725.67 Million ≈ $848.38 Million	+0.15pp
2021-12-31	11.44%	€73.41 Million ≈ $85.82 Million	€641.76 Million ≈ $750.29 Million	-5.07pp
2020-12-31	16.51%	€93.14 Million ≈ $108.89 Million	€564.15 Million ≈ $659.55 Million	+16.24pp
2019-12-31	0.27%	€1.33 Million ≈ $1.55 Million	€493.67 Million ≈ $577.16 Million	+0.19pp
2018-12-31	0.08%	€371.00K ≈ $433.74K	€480.80 Million ≈ $562.11 Million	+0.06pp
2017-12-31	0.02%	€70.00K ≈ $81.84K	€430.24 Million ≈ $503.00 Million	-2.15pp
2016-12-31	2.17%	€7.18 Million ≈ $8.40 Million	€331.22 Million ≈ $387.23 Million	-0.36pp
2015-12-31	2.53%	€7.36 Million ≈ $8.60 Million	€290.68 Million ≈ $339.83 Million	+0.08pp
2014-12-31	2.45%	€6.55 Million ≈ $7.66 Million	€267.23 Million ≈ $312.42 Million	+0.10pp
2013-12-31	2.35%	€6.71 Million ≈ $7.84 Million	€285.16 Million ≈ $333.38 Million	+0.40pp
2012-12-31	1.95%	€5.60 Million ≈ $6.55 Million	€286.84 Million ≈ $335.35 Million	-0.23pp
2011-12-31	2.18%	€6.34 Million ≈ $7.41 Million	€291.12 Million ≈ $340.35 Million	-1.26pp
2010-12-31	3.44%	€10.22 Million ≈ $11.94 Million	€297.10 Million ≈ $347.34 Million	-1.41pp
2009-12-31	4.85%	€11.45 Million ≈ $13.39 Million	€235.97 Million ≈ $275.87 Million	+1.42pp
2008-12-31	3.43%	€9.44 Million ≈ $11.04 Million	€275.01 Million ≈ $321.52 Million	-2.24pp
2007-12-31	5.67%	€15.45 Million ≈ $18.07 Million	€272.43 Million ≈ $318.50 Million	-1.47pp
2006-12-31	7.14%	€16.59 Million ≈ $19.39 Million	€232.43 Million ≈ $271.74 Million	+0.66pp
2005-12-31	6.48%	€13.99 Million ≈ $16.36 Million	€216.04 Million ≈ $252.58 Million	-0.67pp
2004-12-31	7.15%	€14.25 Million ≈ $16.66 Million	€199.29 Million ≈ $232.99 Million	+0.98pp
2003-12-31	6.17%	€12.21 Million ≈ $14.28 Million	€198.01 Million ≈ $231.49 Million	-4.20pp
2002-12-31	10.36%	€18.33 Million ≈ $21.43 Million	€176.91 Million ≈ $206.83 Million	-8.59pp
2001-12-31	18.95%	€4.66 Billion ≈ $5.45 Billion	€24.57 Billion ≈ $28.73 Billion	-1.16pp
2000-12-31	20.12%	€4.87 Billion ≈ $5.69 Billion	€24.21 Billion ≈ $28.30 Billion	--

pp = percentage points

About Faes Farma SA

MC:FAE Spain Drug Manufacturers - Specialty & Generic

Market Cap

$1.77 Billion

€1.51 Billion EUR

Market Cap Rank

#7407 Global

#60 in Spain

Share Price

€4.86

Change (1 day)

+2.53%

52-Week Range

€4.13 - €5.38

All Time High

€5.38